
Blood Cancer United and BeOne Medicines Expand Three-Year Partnership
A fresh $5 million investment from BeOne Medicines will fuel a three-year expansion of patient support services at Blood Cancer United. The collaboration aims to broaden access to educational resources and community programs, targeting a ambitious organizational goal of adding one million years of life to patients by 2040.


























